Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 18, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 12, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 22, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 22, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 22, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 22, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 14, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 14, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 14, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 14, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 10, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 10, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 18, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare genetic diseases and disorders
Classification
International Classes
005